L LLY

Lilly(Eli) & Company

DRUG MANUFACTURERS - GENERAL · HEALTHCARE

Eli Lilly and Company (Ticker: LLY), headquartered in Indianapolis, Indiana, is a leading global pharmaceutical entity distinguished for its cutting-edge advancements in healthcare. The company primarily concentrates on therapeutic areas including diabetes, oncology, and neurodegenerative diseases, ...

$1,004.92

-0.01% ($0.05)

Volume 2.82M

52W High $1,133.95

52W Low $621.54

Market Cap $821.87B

← Back to Calendar Compare with Others →

Next Earnings Report

Last Reported

Apr 30, 2026 Beat

Actual: $8.55 vs. Consensus: $7.25

Price Chart

EPS History: Consensus vs Actual

Last 12 quarters

Price Movement Around Earnings

Q1 2026 Apr 30, 2026

1-Day: +3.07%

5-Day: +5.81%

Q4 2025 Feb 11, 2026

1-Day: +2.27%

Q4 2025 Feb 4, 2026

1-Day: -7.79%

5-Day: -5.64%

Q3 2025 Oct 30, 2025

1-Day: +2.17%

5-Day: +7.38%

Revenue & Financial Performance

Quarter	Revenue	YoY Growth	Gross Margin	Op Margin	Net Income
Q1'26	$19.80B	+55.6%	81.9%	44.7%	$7.40B
Q4'25	$19.29B	+42.6%	85.1%	45.5%	$6.64B
Q3'25	$17.60B	+53.9%	82.9%	47.7%	$5.58B
Q2'25	$15.56B	+37.6%	84.3%	45.8%	$5.66B
Q1'25	$12.73B	+45.2%	82.5%	42.5%	$2.76B
Q4'24	$13.53B	+44.7%	82.2%	42.8%	$4.41B
Q3'24	$11.44B	+20.4%	81.0%	39.8%	$970.3M
Q2'24	$11.30B	+36.0%	80.8%	39.1%	$2.97B

Historical Earnings

Last 12 quarters

Quarter	Date	Consensus	Whisper	Actual EPS	Surprise %	Result
Q1 2026	Apr 30, 2026	$7.25	$7.15	$8.55	+17.93%	Beat
Q4 2025	Feb 11, 2026	$7.17	$7.45	$7.54	+5.16%	Beat
Q4 2025	Feb 4, 2026	$7.17	$7.49	$7.54	+5.16%	Met
Q3 2025	Oct 30, 2025	$6.37	$6.36	$7.02	+10.20%	Beat
Q2 2025	Aug 7, 2025	$5.59	$5.83	$6.31	+12.88%	Beat
Q1 2025	May 1, 2025	$3.54	$3.79	$3.34	-5.65%	Missed
Q4 2024	Feb 6, 2025	$5.07	$5.44	$5.32	+5.00%	Missed
Q3 2024	Oct 30, 2024	$1.47	$1.69	$1.18	-19.73%	Missed
Q2 2024	Aug 8, 2024	$2.60	$2.99	$3.92	+50.77%	Beat
Q1 2024	Apr 30, 2024	$2.46	$2.83	$2.58	+4.88%	Missed
Q4 2023	Feb 6, 2024	$2.22	$2.55	$2.49	+12.16%	Missed
Q3 2023	Nov 2, 2023	-$0.13	-$0.13	$0.10	--	Beat